Pitfalls of exome sequencing: a case study of the attribution of HABP2 rs7080536 in familial non-medullary thyroid cancer
- PMID: 28884020
- PMCID: PMC5584869
- DOI: 10.1038/s41525-017-0011-x
Pitfalls of exome sequencing: a case study of the attribution of HABP2 rs7080536 in familial non-medullary thyroid cancer
Abstract
Next-generation sequencing using exome capture is a common approach used for analysis of familial cancer syndromes. Despite the development of robust computational algorithms, the accrued experience of analyzing exome data sets and published guidelines, the analytical process remains an ad hoc series of important decisions and interpretations that require significant oversight. Processes and tools used for sequence data generation have matured and are standardized to a significant degree. For the remainder of the analytical pipeline, however, the results can be highly dependent on the choices made and careful review of results. We used primary exome sequence data, generously provided by the corresponding author, from a family with highly penetrant familial non-medullary thyroid cancer reported to be caused by HABP2 rs7080536 to review the importance of several key steps in the application of exome sequencing for discovery of new familial cancer genes. Differences in allele frequencies across populations, probabilities of familial segregation, functional impact predictions, corroborating biological support, and inconsistent replication studies can play major roles in influencing interpretation of results. In the case of HABP2 rs7080536 and familial non-medullary thyroid cancer, these factors led to the conclusion of an association that most data and our re-analysis fail to support, although larger studies from diverse populations will be needed to definitively determine its role.
Conflict of interest statement
COMPETING INTERESTS The authors declare no competing interests.
Similar articles
-
The HABP2 G534E variant is an unlikely cause of familial non-medullary thyroid cancer.J Clin Endocrinol Metab. 2016 Mar 1;10(3):1098-1103. doi: 10.1210/jc.2015-3928. Epub 2015 Dec 21. J Clin Endocrinol Metab. 2016. PMID: 26691890 Free PMC article.
-
Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2): insights from a large series of familial non-medullary thyroid cancers and literature review.Clin Endocrinol (Oxf). 2017 Jun;86(6):837-844. doi: 10.1111/cen.13316. Epub 2017 Mar 23. Clin Endocrinol (Oxf). 2017. PMID: 28222214
-
Letter regarding the article: "Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls" by Kern et al.Eur J Med Genet. 2018 Feb;61(2):104-105. doi: 10.1016/j.ejmg.2017.07.012. Epub 2017 Aug 2. Eur J Med Genet. 2018. PMID: 28779995
-
Familial non-medullary thyroid cancer: unraveling the genetic maze.Endocr Relat Cancer. 2016 Dec;23(12):R577-R595. doi: 10.1530/ERC-16-0067. Epub 2016 Nov 2. Endocr Relat Cancer. 2016. PMID: 27807061 Review.
-
Genetic susceptibility to hereditary non-medullary thyroid cancer.Hered Cancer Clin Pract. 2022 Mar 7;20(1):9. doi: 10.1186/s13053-022-00215-3. Hered Cancer Clin Pract. 2022. PMID: 35255942 Free PMC article. Review.
Cited by
-
Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates.Endocr Pathol. 2021 Mar;32(1):77-101. doi: 10.1007/s12022-020-09661-y. Epub 2021 Jan 25. Endocr Pathol. 2021. PMID: 33495912 Free PMC article. Review.
-
To the editor.NPJ Genom Med. 2017 Jun 30;2:21. doi: 10.1038/s41525-017-0026-3. eCollection 2017. NPJ Genom Med. 2017. PMID: 29263832 Free PMC article. No abstract available.
-
Reporting of race in genome and exome sequencing studies of cancer: a scoping review of the literature.Genet Med. 2019 Dec;21(12):2676-2680. doi: 10.1038/s41436-019-0558-2. Epub 2019 Jun 4. Genet Med. 2019. PMID: 31160752 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous